24O0.MU Stock Analysis
24
Uncovered
ReShape Lifesciences Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.005
Dividend yield
—
Shares outstanding
0.519 B
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 47 full-time employees. The company went IPO on 2016-10-06. The firm is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching program is a reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShape Marketplace is an online store, that provides a line of products for bariatric patients. Its ReShape Optimize supplement options include multivitamins, probiotics, calcium, vitamin D, protein and other therapeutic offerings to optimize health. Its ReShape Vest is an investigational, minimally invasive, laparoscopically implanted medical device.